Galanin-2 receptor agonists

A chimeric protein targeting the galanin receptor addresses the inadequacies of existing pain treatments by engaging the galanin receptor system, providing an effective pain relief mechanism.

HK40134716APending Publication Date: 2026-07-10LIFEARC
View PDF 0 Cites 0 Cited by

Patent Information

Authority / Receiving Office
HK · HK
Patent Type
Applications
Current Assignee / Owner
LIFEARC
Filing Date
2026-04-27
Publication Date
2026-07-10

Smart Images

  • Figure 00000043_0000
    Figure 00000043_0000
  • Figure 00000043_0001
    Figure 00000043_0001
  • Figure 00000044_0000
    Figure 00000044_0000
Patent Text Reader

Abstract

The invention related to a chimeric protein comprising (i) a galanin fragment consisting of residues 2-13 of galanin (Gal2-13) or residues 2-13 of galanin (Gal2-12) or a variant thereof, and (ii) an FC region and well as pharmaceutical composition comprising these proteins. These proteins are suitable for use in the treatment of pain.
Need to check novelty before this filing date? Find Prior Art